ACE inhibitors and aortic rupture

FA Lederle, BC Taylor - The Lancet, 2006 - thelancet.com
found that use of an angiotensin-converting-enzyme (ACE) inhibitor in the past year,
including the past 3 months, was negatively associated with admission for ruptured …

Angiotensin-converting enzyme inhibitors and aortic rupture: a population-based case-control study

DG Hackam, D Thiruchelvam, DA Redelmeier - The Lancet, 2006 - thelancet.com
Background Angiotensin-converting enzyme (ACE) inhibitors prevent the expansion and
rupture of aortic aneurysms in animals. We investigated the association between ACE …

ACE inhibitors and abdominal aortic aneurysm

N Diehm, I Baumgartner - The Lancet, 2006 - thelancet.com
Abdominal aortic aneurysm is a potentially fatal disorder, defined as a focal dilatation
exceeding 150% of the normal arterial diameter, with the risk for rupture increasing as …

Why deny ACE inhibitors to patients with aortic stenosis?

NLT Cox, AR Abdul-Hamid, GP Mulley - The Lancet, 1998 - thelancet.com
Martinez-Sanchez C, Henne O, Arceo A, et al. Hemodynamic 22 patients, median Mean
aortic valve Captopril Case series: all patients given captopril effects of oral captopril in …

[HTML][HTML] Use of angiotensin converting enzyme inhibitors is associated with increased growth rate of abdominal aortic aneurysms

MJ Sweeting, SG Thompson, LC Brown… - Journal of vascular …, 2010 - Elsevier
OBJECTIVES: To evaluate whether either angiotensin converting enzyme (ACE) inhibitors
or other classes of antihypertensive drug attenuate or increase growth rates of small …

Aortic stenosis and ACE inhibitors

H Rimington, S Takeda, J Chambers - The Lancet, 1998 - thelancet.com
Niall Cox and co-workers (July 11, p 111) 1 suggest that “vasodilatation is safe in patients
with aortic stenosis”. However this statement is likely to be true only if the left venticle can …

Systematic Review Examining the Association of Angiotensin Converting Enzyme Inhibitor and Angiotensin Receptor Blocker Prescription with Abdominal Aortic …

K Tian, S Thanigaimani, K Gibson… - European Journal of …, 2024 - Elsevier
Objective Whether angiotensin II blockade is an effective medical treatment for abdominal
aortic aneurysms (AAAs) has not been established. This systematic review and meta …

Interpretation in drug epidemiology

JØH Olsen - The Lancet, 1998 - thelancet.com
See page 179 A formidable challenge for epidemiologists is the interpretation of statistically
significant findings that arise after multiple comparisons in data previously analysed. The …

[引用][C] Control of hypotension following removal of aortic clamps

JR Kenyon, KE Cooper - The Lancet, 1956 - Elsevier
physician-in-charge. Other visits, however, simply for these operations were performed is shown
in fig. 1. plethysmograph was wa Page 1 543 clinic for examination at intervals determined by …

Angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in patients with abdominal aortic aneurysms: nation-wide cohort study

KE Kristensen, C Torp-Pedersen… - … , and vascular biology, 2015 - Am Heart Assoc
Objective—The renin–angiotensin system is thought to play a pivotal role in the
pathogenesis of abdominal aortic aneurysms (AAAs). However, effects of angiotensin …